The FDA’s Risk Evaluation and Mitigation Strategies (REMS) program ensures valuable medicines that would not otherwise be on the market are available for patients who need them, including women. REMS allows access to treatments for conditions that impact women at higher rates, including mental health disorders, irritable bowel syndrome, and sexual dysfunction. Read more here.
Last Updated on May 13, 2020 by Aimed Alliance
